Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Restoring the capacity of endothelial progenitor cells (EPCs) to promote angiogenesis is the major therapeutic strategy of diabetic peripheral artery disease. The aim of this study was to investigate the effects of GLP-1 (glucagon-like peptide 1; 32–36)—an end product of GLP-1—on angiogenesis of EPCs and T1DM (type 1 diabetes) mice, as well as its interaction with the classical GLP-1R (GLP-1 receptor) pathway and its effect on mitochondrial metabolism.METHODS:In in vivo experiments, we conducted streptozocin-induced type 1 diabetic mice as a murine model of unilateral hind limb ischemia to examine the therapeutic potential of GLP-1(32–36) on angiogenesis. We also generatedGlp1r−/−mice to detect whether GLP-1R is required for angiogenic function of GLP-1(32–36). In in vitro experiments, EPCs isolated from the mouse bone marrow and human umbilical cord blood samples were used to detect GLP-1(32–36)–mediated angiogenic capability under high glucose treatment.RESULTS:We demonstrated that GLP-1(32–36) did not affect insulin secretion but could significantly rescue angiogenic function and blood perfusion in ischemic limb of streptozocin-induced T1DM mice, a function similar to its parental GLP-1. We also found that GLP-1(32–36) promotes angiogenesis in EPCs exposed to high glucose. Specifically, GLP-1(32–36) has a causal role in improving fragile mitochondrial function and metabolism via the GLP-1R–mediated pathway. We further demonstrated that GLP-1(32–36) rescued diabetic ischemic lower limbs by activating the GLP-1R–dependent eNOS (endothelial NO synthase)/cGMP/PKG (protein kinase G) pathway.CONCLUSIONS:Our study provides a novel mechanism with which GLP-1(32–36) acts in modulating metabolic reprogramming toward glycolytic flux in partnership with GLP-1R for improved angiogenesis in high glucose–exposed EPCs and T1DM murine models. We propose that GLP-1(32–36) could be used as a monotherapy or add-on therapy with existing treatments for peripheral artery disease.REGISTRATION:URL:www.ebi.ac.uk/metabolights/; Unique identifier: MTBLS9543.

A Novel Rhynchophylline Analog, Y396, Inhibits Endothelial Dysfunction Induced by Oxidative Stress in Diabetes Through Epidermal Growth Factor Receptor

TCTAP A-055 Novel Rhynchophylline Analogue, Y396, Improves Endothelial Malfunction Induced by Oxidative Stress in Diabetes

A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration.

A Novel Angiogenesis Role of GLP-1(32-36) to Rescue Diabetic Ischemic Lower Limbs Via GLP-1R-Dependent Glycolysis

Liraglutide Prevents High Glucose Induced HUVECs Dysfunction Via Inhibition of PINK1/Parkin-dependent Mitophagy

Phloretin Ameliorates Diabetes-Induced Endothelial Injury Through AMPK-dependent Anti-Endmt Pathway

Ginsenoside Rk1 improves endothelial function in diabetes through activating peroxisome proliferator-activated receptors

Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway

387-P: Novel Mitochondrial Complex I Modulator Reduces Diabetes-Associated Expression of Inflammation and Fibrosis Markers in Human Proximal Tubular Epithelial Cells

Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET-1/Nox4 signal pathway in diabetic rats

aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2

Rhynchophylline Ameliorates Endothelial Dysfunction Via Src-PI3K/Akt-eNOS Cascade in the Cultured Intrarenal Arteries of Spontaneous Hypertensive Rats

Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF-1α/VEGF via Activating Nrf2 Antioxidant Pathway

NRF2-HIF2α Signaling Attenuates Endothelial Cell Senescence and Maintains Intercellular Junctions in Diabetes

EGFR Inhibition Attenuates Diabetic Nephropathy Through Decreasing ROS and Endoplasmic Reticulum Stress

Novel Angiogenesis Role of GLP-1(32–36) to Rescue Diabetic Ischemic Lower Limbs via GLP-1R–Dependent Glycolysis in Mice

Natural diterpenoid EKO activates deubiqutinase ATXN3 to preserve vascular endothelial integrity and alleviate diabetic retinopathy through c-fos/focal adhesion axis

Novel Rhynchophylline Analogues As Microvascular Relaxation Agents for the Treatment of Microvascular Dysfunction Caused by Diabetes

PPARδ Agonist Prevents Endothelial Dysfunction Via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway

Abstract 461: Enhanced Glycolysis in Endothelial Cells Protects Against Atherosclerosis

EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress.